Site Search     
 
  Dendritic Cell Based Cancer Vaccines
  Genes of Health: Signature of Health and Disease in Humans
  Human Dendritic Cell Biology
  Humouse: An In Vivo Model of the Human Immune System
  Infectious Diseases
  Understanding of Systemic Lupus Erythematosus
  Current BIIR Grants
  Key BIIR Papers
Key BIIR Papers
Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25:383-392.

Different genetic alterations may lead to type I interferon (IFN) overproduction in human systemic lupus erythematosus (SLE). The increased bioavailability of type I IFN contributes to peripheral tolerance breakdown through the activation of immature myeloid dendritic cells (mDCs). IFN-matured mDCs activate autoreactive T cells. These cells, together with plasmacytoid DCs, help expand autoreactive B cells. IFN-matured DCs also activate cytotoxic CD8(+) T cells, possibly increasing apoptotic cell availability. The capture of apoptotic cells by mDCs and of nucleic acid-containing immune complexes by plasmacytoid DCs and B cells amplifies the autoimmune reaction leading to disease manifestations. Genetic alterations in lineages other than B cells might explain other autoimmune syndromes where type I IFNs appear to be involved.